Is Lurasidone Safe with Weight Gain Risk?

While antipsychotic medications have significantly improved the lives of individuals with severe mental health disorders, the potential for weight gain should not be overlooked.

Antipsychotic medications, both first-generation (typical) and second-generation (atypical), are known to alter the body’s metabolism and appetite regulation. While the exact mechanisms are not fully understood, several factors contribute to this weight gain including increased appetite, metabolic changes and hormonal impact on insulin and leptin.

Understanding the impact of antipsychotic medications on weight gain is essential in providing comprehensive care for patients with mental health conditions. By staying up-to-date with the latest evidence and considerations for clinical practice, we can make informed decisions when prescribing antipsychotic medications, and minimize the risk of weight gain and its associated health consequences.

Watch the following YouTube video on

Understanding the risk of weight gain with Lurasidone :

DETAILED LECTURE FOR ACADEMY MEMBERS:

Antipsychotics & Weight Gain: Update 2023

This video discussion will be answer the following clinically relevant questions:

  • Antipsychotics with the LOWEST and HIGHEST risk of weight gain.
  • Which antipsychotic(s) weight-gain risk is LOWER AT HIGH DOSES?
  • Which antipsychotic(s) weight-gain risk PLATEAUS AT HIGH DOSES?
  • Which antipsychotic(s) weight-gain risk is HIGHER AT HIGH DOSES?
  • Quetiapine XR versus IR formulation: for weight gain and metabolic parameters.
  • Do LONG-ACTING INJECTABLES differ in the risk of weight gain?

Antipsychotics & Weight Gain

FOR ACADEMY MEMBERS
ACADEMY

JOIN EMAIL NEWSLETTER (FREE):

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

  • 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine.
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
GENERAL
$ 150/YR
  •  
STUDENTS
$ 99/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

© 2024 All Rights Reserved.

Related Articles